For a pancreatic body or tail tumor, distal pancreatectomy with splenectomy (DPS) is a standard operation. Spleen-preserving distal pancreatectomy (SPDP) was introduced in order to preserve the organ and, thus, provide the patient with a better quality of life.1 In contrast, despite the fact that intraductal papillary mucinous tumors (IPMTs) have a low but well-documented malignant rate of progression, an aggressive surgical approach is recommended. In addition, these tumors, even when malignant, are often resectable and have a more favorable prognosis than ductal adenocarcinoma and classic mucinous cystadenocarcinoma of the pancreas. These characteristics support limited surgical resection in cases of IPMTs.2 Thus, SPDP is considered as one of the options for the treatment of IPMTs of the body or tail of the pancreas. Here, we report a case of noninvasive intraductal papillary mucinous carcinoma that was treated with SPDP.